24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry

NCT03478761 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-03-20

No results posted yet for this study

Summary

You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.

Conditions

  • 24-hydroxylase Deficiency

Sponsors & Collaborators

Principal Investigators

  • David Sas, MD · Mayo Clinic

  • Peter Tebben, MD · Mayo Clinic

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-19
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03478761 on ClinicalTrials.gov